Jean-Paul Clozel is a prominent figure in the field of pharmaceuticals, currently serving as the CEO of Idorsia Pharmaceuticals. With a strong background in medicine and science, he has dedicated his career to advancing drug development and improving patient outcomes. Based in Western Switzerland, Clozel is recognized as a leader in longevity research and innovation. His commitment to transforming healthcare through cutting-edge therapies has positioned Idorsia as a key player in the industry.